APO Research
Talk to an analyst

APO RESEARCH · REPORT

Antacids

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Antacids Industry Growth and Trends Forecast to 2032

20 December 2025106 pages

Choose your research edition.

Industry ResearchAntacids Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Antacids Industry Growth and Trends Forecast to 2032106 pages · $3,450 USDMarket StructureGlobal Antacids Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Antacids Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Antacids Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Antacids market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Antacids is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Antacids is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Antacids is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Antacids include Xiuzheng Pharma, Takeda Pharmaceutical, Sanofi, Johnson & Johnson, Novartis, Reckitt Benckiser, CONBA, Pfizer and CR SANJIU, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Antacids market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Antacids market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Antacids market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Antacids.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Antacids market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Antacids Market by Company

Xiuzheng Pharma

Takeda Pharmaceutical

Sanofi

Johnson & Johnson

Novartis

Reckitt Benckiser

CONBA

Pfizer

CR SANJIU

GlaxoSmithKline

Bausch Health

Procter & Gamble

Bayer

AstraZeneca

Antacids Segment by Type

Non-Systemic Antacids

Systemic Antacids

Antacids Segment by Application

Rx Drug

OTC Drug

Antacids Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Antacids market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Antacids and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Antacids.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Antacids manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Antacids in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Non-Systemic Antacids Table 2. Major Company of Systemic Antacids Table 3. Global Antacids Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Antacids Sales by Type (2021-2026) & (k units) Table 5. Global Antacids Sales Market Share in Volume by Type (2021-2026) Table 6. Global Antacids Sales by Type (2021-2026) & (US$ Million) Table 7. Global Antacids Sales Market Share in Value by Type (2021-2026) Table 8. Global Antacids Price by Type (2021-2026) & (US$/unit) Table 9. Global Antacids Sales by Type (2027-2032) & (k units) Table 10. Global Antacids Sales Market Share in Volume by Type (2027-2032) Table 11. Global Antacids Sales by Type (2027-2032) & (US$ Million) Table 12. Global Antacids Sales Market Share in Value by Type (2027-2032) Table 13. Global Antacids Price by Type (2027-2032) & (US$/unit) Table 14. North America Antacids Sales by Type (2021-2026) & (k units) Table 15. North America Antacids Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Antacids Sales by Type (2021-2026) & (k units) Table 17. Europe Antacids Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Antacids Sales by Type (2021-2026) & (k units) Table 19. Asia-Pacific Antacids Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Antacids Sales by Type (2021-2026) & (k units) Table 21. Latin America Antacids Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Antacids Sales by Type (2021-2026) & (k units) Table 23. Middle East and Africa Antacids Sales by Type (2021-2026) & (US$ Million) Table 24. Antacids Industry Trends Table 25. Antacids Industry Drivers Table 26. Antacids Industry Opportunities and Challenges Table 27. Antacids Industry Restraints Table 28. Global Antacids Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Antacids Revenue Market Share by Company (2021-2026) Table 30. Global Antacids Sales by Company (2021-2026) & (k units) Table 31. Global Antacids Sales Share by Company (2021-2026) Table 32. Global Antacids Market Price by Company (2021-2026) & (US$/unit) Table 33. Global Antacids Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Antacids Major Company Production Sites and Headquarters Table 35. Global Antacids Company, Product Type & Application Table 36. Global Antacids Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Antacids by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Antacids Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Antacids Sales by Region (2021-2026) & (k units) Table 41. Global Antacids Sales Market Share in Volume by Region (2021-2026) Table 42. Global Antacids Sales by Region (2021-2026) & (US$ Million) Table 43. Global Antacids Sales Market Share in Value by Region (2021-2026) Table 44. Global Antacids Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 45. Global Antacids Sales by Region (2027-2032) & (k units) Table 46. Global Antacids Sales Market Share in Volume by Region (2027-2032) Table 47. Global Antacids Sales by Region (2027-2032) & (US$ Million) Table 48. Global Antacids Sales Market Share in Value by Region (2027-2032) Table 49. Global Antacids Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2027-2032) Table 50. Global Antacids Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Antacids Sales by Application (2021-2026) & (k units) Table 52. Global Antacids Sales Market Share in Volume by Application (2021-2026) Table 53. Global Antacids Sales by Application (2021-2026) & (US$ Million) Table 54. Global Antacids Sales Market Share in Value by Application (2021-2026) Table 55. Global Antacids Price by Application (2021-2026) & (US$/unit) Table 56. Global Antacids Sales by Application (2027-2032) & (k units) Table 57. Global Antacids Sales Market Share in Volume by Application (2027-2032) Table 58. Global Antacids Sales by Application (2027-2032) & (US$ Million) Table 59. Global Antacids Sales Market Share in Value by Application (2027-2032) Table 60. Global Antacids Price by Application (2027-2032) & (US$/unit) Table 61. North America Antacids Sales by Application (2021-2026) & (k units) Table 62. North America Antacids Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Antacids Sales by Application (2021-2026) & (k units) Table 64. Europe Antacids Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Antacids Sales by Application (2021-2026) & (k units) Table 66. Asia-Pacific Antacids Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Antacids Sales by Application (2021-2026) & (k units) Table 68. Latin America Antacids Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Antacids Sales by Application (2021-2026) & (k units) Table 70. Middle East and Africa Antacids Sales by Application (2021-2026) & (US$ Million) Table 71. Xiuzheng Pharma Company Information Table 72. Xiuzheng Pharma Business Overview Table 73. Xiuzheng Pharma Antacids Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 74. Xiuzheng Pharma Antacids Product Portfolio Table 75. Xiuzheng Pharma Recent Development Table 76. Takeda Pharmaceutical Company Information Table 77. Takeda Pharmaceutical Business Overview Table 78. Takeda Pharmaceutical Antacids Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 79. Takeda Pharmaceutical Antacids Product Portfolio Table 80. Takeda Pharmaceutical Recent Development Table 81. Sanofi Company Information Table 82. Sanofi Business Overview Table 83. Sanofi Antacids Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 84. Sanofi Antacids Product Portfolio Table 85. Sanofi Recent Development Table 86. Johnson & Johnson Company Information Table 87. Johnson & Johnson Business Overview Table 88. Johnson & Johnson Antacids Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 89. Johnson & Johnson Antacids Product Portfolio Table 90. Johnson & Johnson Recent Development Table 91. Novartis Company Information Table 92. Novartis Business Overview Table 93. Novartis Antacids Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 94. Novartis Antacids Product Portfolio Table 95. Novartis Recent Development Table 96. Reckitt Benckiser Company Information Table 97. Reckitt Benckiser Business Overview Table 98. Reckitt Benckiser Antacids Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 99. Reckitt Benckiser Antacids Product Portfolio Table 100. Reckitt Benckiser Recent Development Table 101. CONBA Company Information Table 102. CONBA Business Overview Table 103. CONBA Antacids Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 104. CONBA Antacids Product Portfolio Table 105. CONBA Recent Development Table 106. Pfizer Company Information Table 107. Pfizer Business Overview Table 108. Pfizer Antacids Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 109. Pfizer Antacids Product Portfolio Table 110. Pfizer Recent Development Table 111. CR SANJIU Company Information Table 112. CR SANJIU Business Overview Table 113. CR SANJIU Antacids Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 114. CR SANJIU Antacids Product Portfolio Table 115. CR SANJIU Recent Development Table 116. GlaxoSmithKline Company Information Table 117. GlaxoSmithKline Business Overview Table 118. GlaxoSmithKline Antacids Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 119. GlaxoSmithKline Antacids Product Portfolio Table 120. GlaxoSmithKline Recent Development Table 121. Bausch Health Company Information Table 122. Bausch Health Business Overview Table 123. Bausch Health Antacids Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 124. Bausch Health Antacids Product Portfolio Table 125. Bausch Health Recent Development Table 126. Procter & Gamble Company Information Table 127. Procter & Gamble Business Overview Table 128. Procter & Gamble Antacids Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 129. Procter & Gamble Antacids Product Portfolio Table 130. Procter & Gamble Recent Development Table 131. Bayer Company Information Table 132. Bayer Business Overview Table 133. Bayer Antacids Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 134. Bayer Antacids Product Portfolio Table 135. Bayer Recent Development Table 136. AstraZeneca Company Information Table 137. AstraZeneca Business Overview Table 138. AstraZeneca Antacids Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 139. AstraZeneca Antacids Product Portfolio Table 140. AstraZeneca Recent Development Table 141. North America Antacids Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 142. North America Antacids Sales by Country (2021-2026) & (k units) Table 143. North America Antacids Sales Market Share by Country (2021-2026) Table 144. North America Antacids Sales Forecast by Country (2027-2032) & (k units) Table 145. North America Antacids Sales Market Share Forecast by Country (2027-2032) Table 146. North America Antacids Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 147. North America Antacids Market Size by Country (2021-2026) & (US$ Million) Table 148. North America Antacids Market Share by Country (2021-2026) Table 149. North America Antacids Market Size Forecast by Country (2027-2032) & (US$ Million) Table 150. North America Antacids Market Share Forecast by Country (2027-2032) Table 151. Europe Antacids Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 152. Europe Antacids Sales by Country (2021-2026) & (k units) Table 153. Europe Antacids Sales Market Share by Country (2021-2026) Table 154. Europe Antacids Sales Forecast by Country (2027-2032) & (k units) Table 155. Europe Antacids Sales Market Share Forecast by Country (2027-2032) Table 156. Europe Antacids Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 157. Europe Antacids Market Size by Country (2021-2026) & (US$ Million) Table 158. Europe Antacids Market Share by Country (2021-2026) Table 159. Europe Antacids Market Size Forecast by Country (2027-2032) & (US$ Million) Table 160. Europe Antacids Market Share Forecast by Country (2027-2032) Table 161. Asia-Pacific Antacids Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 162. Asia-Pacific Antacids Sales by Country (2021-2026) & (k units) Table 163. Asia-Pacific Antacids Sales Market Share by Country (2021-2026) Table 164. Asia-Pacific Antacids Sales Forecast by Country (2027-2032) & (k units) Table 165. Asia-Pacific Antacids Sales Market Share Forecast by Country (2027-2032) Table 166. Asia-Pacific Antacids Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 167. Asia-Pacific Antacids Market Size by Country (2021-2026) & (US$ Million) Table 168. Asia-Pacific Antacids Market Share by Country (2021-2026) Table 169. Asia-Pacific Antacids Market Size Forecast by Country (2027-2032) & (US$ Million) Table 170. Asia-Pacific Antacids Market Share Forecast by Country (2027-2032) Table 171. Latin America Antacids Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 172. Latin America Antacids Sales by Country (2021-2026) & (k units) Table 173. Latin America Antacids Sales Market Share by Country (2021-2026) Table 174. Latin America Antacids Sales Forecast by Country (2027-2032) & (k units) Table 175. Latin America Antacids Sales Market Share Forecast by Country (2027-2032) Table 176. Latin America Antacids Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 177. Latin America Antacids Market Size by Country (2021-2026) & (US$ Million) Table 178. Latin America Antacids Market Share by Country (2021-2026) Table 179. Latin America Antacids Market Size Forecast by Country (2027-2032) & (US$ Million) Table 180. Latin America Antacids Market Share Forecast by Country (2027-2032) Table 181. Middle East and Africa Antacids Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 182. Middle East and Africa Antacids Sales by Country (2021-2026) & (k units) Table 183. Middle East and Africa Antacids Sales Market Share by Country (2021-2026) Table 184. Middle East and Africa Antacids Sales Forecast by Country (2027-2032) & (k units) Table 185. Middle East and Africa Antacids Sales Market Share Forecast by Country (2027-2032) Table 186. Middle East and Africa Antacids Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 187. Middle East and Africa Antacids Market Size by Country (2021-2026) & (US$ Million) Table 188. Middle East and Africa Antacids Market Share by Country (2021-2026) Table 189. Middle East and Africa Antacids Market Size Forecast by Country (2027-2032) & (US$ Million) Table 190. Middle East and Africa Antacids Market Share Forecast by Country (2027-2032) Table 191. Key Raw Materials Table 192. Raw Materials Key Suppliers Table 193. Antacids Distributors List Table 194. Antacids Customers List Table 195. Research Programs/Design for This Report Table 196. Authors List of This Report Table 197. Secondary Sources Table 198. Primary Sources List of Figures Figure 1. Antacids Image Figure 2. Global Antacids Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Antacids Market Size (2021-2032) & (US$ Million) Figure 4. Global Antacids Sales (2021-2032) & (k units) Figure 5. Non-Systemic Antacids Image Figure 6. Global Non-Systemic Antacids Sales YoY Growth (2021-2032) & (k units) Figure 7. Systemic Antacids Image Figure 8. Global Systemic Antacids Sales YoY Growth (2021-2032) & (k units) Figure 9. Global Antacids Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Antacids Market Share by Type 2025 VS 2032 Figure 11. North America Antacids Sales Market Share in Volume by Type in 2025 Figure 12. North America Antacids Sales Market Share in Value by Type in 2025 Figure 13. Europe Antacids Sales Market Share in Volume by Type in 2025 Figure 14. Europe Antacids Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Antacids Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Antacids Sales Market Share in Value by Type in 2025 Figure 17. Latin America Antacids Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Antacids Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Antacids Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Antacids Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Antacids Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Rx Drug Image Figure 24. Global Rx Drug Sales YoY Growth (2021-2032) & (k units) Figure 25. OTC Drug Image Figure 26. Global OTC Drug Sales YoY Growth (2021-2032) & (k units) Figure 27. Global Antacids Market Size Overview by Application (2021-2032) & (US$ Million) Figure 28. Global Antacids Market Share by Application 2025 VS 2032 Figure 29. North America Antacids Sales Market Share in Volume by Application in 2025 Figure 30. North America Antacids Sales Market Share in Value by Application in 2025 Figure 31. Europe Antacids Sales Market Share in Volume by Application in 2025 Figure 32. Europe Antacids Sales Market Share in Value by Application in 2025 Figure 33. Asia-Pacific Antacids Sales Market Share in Volume by Application in 2025 Figure 34. Asia-Pacific Antacids Sales Market Share in Value by Application in 2025 Figure 35. Latin America Antacids Sales Market Share in Volume by Application in 2025 Figure 36. Latin America Antacids Sales Market Share in Value by Application in 2025 Figure 37. Middle East and Africa Antacids Sales Market Share in Volume by Application in 2025 Figure 38. Middle East and Africa Antacids Sales Market Share in Value by Application in 2025 Figure 39. North America Antacids Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 40. North America Antacids Sales Share by Country: 2021 VS 2025 VS 2032 Figure 41. North America Antacids Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 42. North America Antacids Market Share by Country: 2021 VS 2025 VS 2032 Figure 43. Europe Antacids Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 44. Europe Antacids Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Antacids Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe Antacids Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Asia-Pacific Antacids Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 48. Asia-Pacific Antacids Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Antacids Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Asia-Pacific Antacids Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Latin America Antacids Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 52. Latin America Antacids Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Antacids Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Latin America Antacids Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Middle East and Africa Antacids Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 56. Middle East and Africa Antacids Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Antacids Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Middle East and Africa Antacids Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Antacids Value Chain Figure 60. Key Raw Materials Price Figure 61. Manufacturing Cost Structure Figure 62. Antacids Production Mode & Process Figure 63. Direct Comparison with Distribution Share Figure 64. Distributors Profiles Figure 65. Years Considered Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • Non-Systemic Antacids
  • Systemic Antacids
Applications
  • Rx Drug
  • OTC Drug
Companies covered
  • Xiuzheng Pharma
  • Takeda Pharmaceutical
  • Sanofi
  • Johnson & Johnson
  • Novartis
  • Reckitt Benckiser
  • CONBA
  • Pfizer
  • CR SANJIU
  • GlaxoSmithKline
  • Bausch Health
  • Procter & Gamble
  • Bayer
  • AstraZeneca

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Antacids Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Antacids Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Antacids Market by Type
  6. 1.3.1 Non-Systemic Antacids
  7. 1.3.2 Systemic Antacids
  8. 1.4 Global Antacids Market Size by Type
  9. 1.4.1 Global Antacids Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Antacids Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Antacids Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Antacids Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Antacids Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Antacids Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Antacids Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Antacids Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Antacids Industry Trends
  2. 2.2 Antacids Industry Drivers
  3. 2.3 Antacids Industry Opportunities and Challenges
  4. 2.4 Antacids Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Antacids Revenue (2021-2026)
  2. 3.2 Global Top Players by Antacids Sales (2021-2026)
  3. 3.3 Global Top Players by Antacids Price (2021-2026)
  4. 3.4 Global Antacids Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Antacids Major Company Production Sites & Headquarters
  6. 3.6 Global Antacids Company, Product Type & Application
  7. 3.7 Global Antacids Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Antacids Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Antacids Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Antacids Tier 1, Tier 2, and Tier 3
4 Antacids Regional Status and Outlook
  1. 4.1 Global Antacids Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Antacids Historic Market Size by Region
  3. 4.2.1 Global Antacids Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Antacids Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Antacids Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Antacids Forecasted Market Size by Region
  7. 4.3.1 Global Antacids Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Antacids Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Antacids Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Antacids by Application
  1. 5.1 Antacids Market by Application
  2. 5.1.1 Rx Drug
  3. 5.1.2 OTC Drug
  4. 5.2 Global Antacids Market Size by Application
  5. 5.2.1 Global Antacids Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Antacids Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Antacids Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Antacids Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Antacids Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Antacids Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Antacids Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Antacids Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Xiuzheng Pharma
  2. 6.1.1 Xiuzheng Pharma Company Information
  3. 6.1.2 Xiuzheng Pharma Business Overview
  4. 6.1.3 Xiuzheng Pharma Antacids Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Xiuzheng Pharma Antacids Product Portfolio
  6. 6.1.5 Xiuzheng Pharma Recent Developments
  7. 6.2 Takeda Pharmaceutical
  8. 6.2.1 Takeda Pharmaceutical Company Information
  9. 6.2.2 Takeda Pharmaceutical Business Overview
  10. 6.2.3 Takeda Pharmaceutical Antacids Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Takeda Pharmaceutical Antacids Product Portfolio
  12. 6.2.5 Takeda Pharmaceutical Recent Developments
  13. 6.3 Sanofi
  14. 6.3.1 Sanofi Company Information
  15. 6.3.2 Sanofi Business Overview
  16. 6.3.3 Sanofi Antacids Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Sanofi Antacids Product Portfolio
  18. 6.3.5 Sanofi Recent Developments
  19. 6.4 Johnson & Johnson
  20. 6.4.1 Johnson & Johnson Company Information
  21. 6.4.2 Johnson & Johnson Business Overview
  22. 6.4.3 Johnson & Johnson Antacids Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Johnson & Johnson Antacids Product Portfolio
  24. 6.4.5 Johnson & Johnson Recent Developments
  25. 6.5 Novartis
  26. 6.5.1 Novartis Company Information
  27. 6.5.2 Novartis Business Overview
  28. 6.5.3 Novartis Antacids Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Novartis Antacids Product Portfolio
  30. 6.5.5 Novartis Recent Developments
  31. 6.6 Reckitt Benckiser
  32. 6.6.1 Reckitt Benckiser Company Information
  33. 6.6.2 Reckitt Benckiser Business Overview
  34. 6.6.3 Reckitt Benckiser Antacids Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Reckitt Benckiser Antacids Product Portfolio
  36. 6.6.5 Reckitt Benckiser Recent Developments
  37. 6.7 CONBA
  38. 6.7.1 CONBA Company Information
  39. 6.7.2 CONBA Business Overview
  40. 6.7.3 CONBA Antacids Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 CONBA Antacids Product Portfolio
  42. 6.7.5 CONBA Recent Developments
  43. 6.8 Pfizer
  44. 6.8.1 Pfizer Company Information
  45. 6.8.2 Pfizer Business Overview
  46. 6.8.3 Pfizer Antacids Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Pfizer Antacids Product Portfolio
  48. 6.8.5 Pfizer Recent Developments
  49. 6.9 CR SANJIU
  50. 6.9.1 CR SANJIU Company Information
  51. 6.9.2 CR SANJIU Business Overview
  52. 6.9.3 CR SANJIU Antacids Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 CR SANJIU Antacids Product Portfolio
  54. 6.9.5 CR SANJIU Recent Developments
  55. 6.10 GlaxoSmithKline
  56. 6.10.1 GlaxoSmithKline Company Information
  57. 6.10.2 GlaxoSmithKline Business Overview
  58. 6.10.3 GlaxoSmithKline Antacids Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 GlaxoSmithKline Antacids Product Portfolio
  60. 6.10.5 GlaxoSmithKline Recent Developments
  61. 6.11 Bausch Health
  62. 6.11.1 Bausch Health Company Information
  63. 6.11.2 Bausch Health Business Overview
  64. 6.11.3 Bausch Health Antacids Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Bausch Health Antacids Product Portfolio
  66. 6.11.5 Bausch Health Recent Developments
  67. 6.12 Procter & Gamble
  68. 6.12.1 Procter & Gamble Company Information
  69. 6.12.2 Procter & Gamble Business Overview
  70. 6.12.3 Procter & Gamble Antacids Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Procter & Gamble Antacids Product Portfolio
  72. 6.12.5 Procter & Gamble Recent Developments
  73. 6.13 Bayer
  74. 6.13.1 Bayer Company Information
  75. 6.13.2 Bayer Business Overview
  76. 6.13.3 Bayer Antacids Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Bayer Antacids Product Portfolio
  78. 6.13.5 Bayer Recent Developments
  79. 6.14 AstraZeneca
  80. 6.14.1 AstraZeneca Company Information
  81. 6.14.2 AstraZeneca Business Overview
  82. 6.14.3 AstraZeneca Antacids Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 AstraZeneca Antacids Product Portfolio
  84. 6.14.5 AstraZeneca Recent Developments
7 North America by Country
  1. 7.1 North America Antacids Sales by Country
  2. 7.1.1 North America Antacids Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Antacids Sales by Country (2021-2026)
  4. 7.1.3 North America Antacids Sales Forecast by Country (2027-2032)
  5. 7.2 North America Antacids Market Size by Country
  6. 7.2.1 North America Antacids Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Antacids Market Size by Country (2021-2026)
  8. 7.2.3 North America Antacids Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Antacids Sales by Country
  2. 8.1.1 Europe Antacids Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Antacids Sales by Country (2021-2026)
  4. 8.1.3 Europe Antacids Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Antacids Market Size by Country
  6. 8.2.1 Europe Antacids Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Antacids Market Size by Country (2021-2026)
  8. 8.2.3 Europe Antacids Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Antacids Sales by Country
  2. 9.1.1 Asia-Pacific Antacids Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Antacids Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Antacids Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Antacids Market Size by Country
  6. 9.2.1 Asia-Pacific Antacids Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Antacids Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Antacids Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Antacids Sales by Country
  2. 10.1.1 South America Antacids Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Antacids Sales by Country (2021-2026)
  4. 10.1.3 South America Antacids Sales Forecast by Country (2027-2032)
  5. 10.2 South America Antacids Market Size by Country
  6. 10.2.1 South America Antacids Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Antacids Market Size by Country (2021-2026)
  8. 10.2.3 South America Antacids Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Antacids Sales by Country
  2. 11.1.1 Middle East and Africa Antacids Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Antacids Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Antacids Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Antacids Market Size by Country
  6. 11.2.1 Middle East and Africa Antacids Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Antacids Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Antacids Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Antacids Value Chain Analysis
  2. 12.1.1 Antacids Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Antacids Production Mode & Process
  7. 12.2 Antacids Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Antacids Distributors
  10. 12.2.3 Antacids Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst